Search
Advanced search

Company search

Company/VAT no/Free text Country/City/Municipality

NET PROFIT (x1000 EUR)

EMPLOYEES

Share

Eurofins Biopharma Product Testing Denmark A/S

Closing information (x1000 EUR)

Closing information 2024/12 2021/12 2020/12
Turnover 0 Equal arrow 0 Equal arrow 0
Earnings before taxes 1,848 More Arrow 1,994 Less Arrow 1,681
Total assets 11,615 Less Arrow 6,631 Less Arrow 6,033
Current assets 8,006 Less Arrow 5,387 Less Arrow 5,035
Current liabilities 8,124 Less Arrow 2,889 More Arrow 3,032
Equity capital 3,023 Less Arrow 2,494 Less Arrow 1,747
- share capital 94 Equal arrow 94 Equal arrow 94
Employees (average) 75 Equal arrow 75 Equal arrow 75

Financial ratios

Fiscal year 2024/12 2021/12 2020/12
Solvency 26.0% More Arrow 37.6% Less Arrow 29.0%
Turnover per employee 0 Equal arrow 0 Equal arrow 0
Profit as a percentage of turnover
Return on assets (ROA)
Current ratio 98.5% More Arrow 186.5% Less Arrow 166.1%
Return on equity (ROE) 61.1% More Arrow 80.0% More Arrow 96.2%
Change turnover 0 Equal arrow 0 Equal arrow 0
Change turnover %
Chg. No. of employees 0 Equal arrow 0 Equal arrow 0
Chg. No. of employees % 0% Equal arrow 0% Equal arrow 0%

Total value of public sale

Fiscal year 2024/12 2021/12 2020/12
Total value of public sale 0 Equal arrow 0 Equal arrow 0

Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank

The closing information is gathered directly from the companies or from Creditsafe.